Lee Bennett

Publications

• Health-Related Quality of Life Outcomes With Two Different Starting Doses of Lenvatinib in Combination With Everolimus for Previously Treated Renal Cell Carcinoma. , The oncologist (2022)
• Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study. , The Lancet. Oncology (2022)
• Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial. , The lancet. Gastroenterology & hepatology (2021)
• Patients' satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors. , Journal of patient-reported outcomes (2021)
• Utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine from an observational study in Europe. , Cephalalgia : an international journal of headache (2017)
• Health-related quality of life and disease symptoms in postmenopausal women with HR(+), HER2(-) advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy. , Current medical research and opinion (2013)
• Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial. , Cancer (2013)
• Health-related quality of life in patients with metastatic colorectal cancer treated with panitumumab in first- or second-line treatment. , British journal of cancer (2011)
• Health-related quality of life and colorectal cancer-specific symptoms in patients with chemotherapy-refractory metastatic disease treated with panitumumab. , International journal of colorectal disease (2010)
• Help-seeking behavior of women with self-reported distressing sexual problems. , Journal of women's health (2002) (2009)

View all publications